FXYD3 and intrahepatic cholangiocarcinoma: An siFXYD3 nano‐delivery system (siFXYD3@PEP) for treating an orthotopic xenograft tumor model of ICC was developed to investigate the possibility of FXYD3 as a therapeutic target for anticancer treatment (Figure 9A, left).